CD10 − /ALDH − Cells are the Sole Cisplatin-Resistant Component of a Novel Ovarian Cancer Stem Cell Hierarchy

Authors

Brendan Ffrench, University of Dublin,Trinity College
Claudia Gasch, University of Dublin, Trinity College
Karsten Hokamp, University of Dublin, Trinity College
Cathy Spillane, University of Dublin, Trinity College
Gordon Blackshields, Pathology Research Laboratory, Coombe Women and Infant ’ s University Hospital, Dublin 8, Ireland
Thamir Mahmoud Mahgoub, University of Dublin, Trinity College
Mark Bates, University of Dublin, Trinity College
Louise Kehoe, University of Dublin, Trinity College
Aoibhinn Mooney, Technological University Dublin
Ronan Doyle, University of Dublin, Trinity College
Brendan Doyle, University of Dublin, Trinity College
Dearbhaile O ’ Donnell, University of Dublin, Trinity College
Noreen Gleeson, University of Dublin, Trinity College
Bryan T Hennessy, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
Britta Stordal, Department of Natural Sciences, Middlesex University, Hendon, London, UK
Ciaran O ’ Riain, University of Dublin, Trinity College
Helen Lambkin, Technological University Dublin

Document Type

Article

Rights

Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence

Disciplines

1. NATURAL SCIENCES

Publication Details

Cell Death and Disease (2017) 8, e3128; doi:10.1038/cddis.2017.379

DOI

10.1038/cddis.2017.379

Recommended Citation

Ffrench, B. (2017) CD10 − /ALDH − Cells are the Sole Cisplatin-Resistant Component of a Novel Ovarian Cancer Stem Cell Hierarchy, Cell Death and Disease (2017) 8, e3128; doi:10.1038/cddis.2017.379